Internal Medicine, Gastroenterology · Brooklyn, NY
NPI
1851377394
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
2035 Ralph Ave, A2
Brooklyn, NY, 11234
Phone (718) 339-2621
Groups this clinician bills Medicare through
Medicare paid, 2024
$100K
1,998 services
Medicare patients, 2024
274
Average age 72
Drug cost, 2024
$1.4M
1,136 prescriptions
Company payments, 2025
$96K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sam Moskowitz was code 88305 (surgical pathology examination), 472 times for 79 patients. In total Sam Moskowitz billed 1,998 services in 31 codes, and Medicare paid $100K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-06-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 472 | 79 | $31.22 | $15K |
| 88313 Surgical Pathology Examination | Office | 382 | 61 | $10.27 | $3,923 |
| 88342 Immunohistochemistry | Office | 227 | 61 | $29.27 | $6,644 |
| 99214 Office E&M - Established | Office | 131 | 90 | $96.02 | $13K |
| 99213 Office E&M - Established | Office | 130 | 108 | $72.23 | $9,389 |
| 99212 Office E&M - Established | Office | 126 | 91 | $31.86 | $4,014 |
| 88377 Immunohistochemistry | Office | 91 | 23 | $52.91 | $4,815 |
| 45378 Lower GI Endoscopy - Other | Facility | 73 | 72 | $167.72 | $12K |
| 43239 Upper GI Endoscopy | Facility | 52 | 51 | $90.49 | $4,705 |
| 88341 Immunohistochemistry | Office | 52 | 19 | $23.52 | $1,223 |
| 99203 Office E&M - New | Office | 50 | 50 | $97.31 | $4,866 |
| 88312 Surgical Pathology Examination | Office | 43 | 20 | $22.37 | $962 |
| 99202 Office E&M - New | Office | 32 | 32 | $56.21 | $1,799 |
| 45380 Lower GI Endoscopy - Other | Facility | 31 | 30 | $166.70 | $5,168 |
| 99204 Office E&M - New | Office | 23 | 23 | $149.54 | $3,439 |
By year: 2022 $111K for 2,254 services; 2023 $104K for 2,151 services; 2024 $100K for 1,998 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 472 | 79 | $31.22 | $15K |
| 88313 Surgical Pathology Examination | 382 | 61 | $10.27 | $3,923 |
| 88342 Immunohistochemistry | 227 | 61 | $29.27 | $6,644 |
| 88377 Immunohistochemistry | 91 | 23 | $52.91 | $4,815 |
| 88341 Immunohistochemistry | 52 | 19 | $23.52 | $1,223 |
| 88312 Surgical Pathology Examination | 43 | 20 | $22.37 | $962 |
| 88360 Immunohistochemistry | 15 | 15 | $34.77 | $522 |
Medicare prescription drug claims, 2024
In 2024, the drug Sam Moskowitz prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 125 prescriptions and refills. In total Sam Moskowitz wrote 1,136 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 125 | 125 | 125 | $6,579 |
| Omeprazole Generic | 112 | 324 | 59 | $1,864 |
| Linzess Linaclotide | 67 | 157 | 27 | $80K |
| Mounjaro Tirzepatide | 55 | 55 | Under 11 | $55K |
| Dexlansoprazole Dr Dexlansoprazole | 47 | 116 | 29 | $16K |
| Voquezna Vonoprazan Fumarate | 46 | 74 | 23 | $44K |
| Famotidine Generic | 41 | 113 | 23 | $751 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 39 | 39 | 38 | $5,350 |
| Procto-Med Hc Hydrocortisone | 39 | 42 | 22 | $307 |
| Xifaxan Rifaximin | 34 | 34 | 20 | $75K |
| Lactulose Generic | 33 | 76 | Under 11 | $151K |
| Ozempic Semaglutide | 27 | 35 | Under 11 | $32K |
| Creon Lipase/Protease/Amylase | 26 | 65 | 11 | $155K |
| Amitriptyline Hcl Generic | 25 | 74 | 14 | $397 |
| Ibsrela Tenapanor Hcl | 25 | 61 | Under 11 | $102K |
Brand drugs: - claims; generic drugs: 656 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sam Moskowitz $96K ($96K in general payments such as food, travel and fees) from 15 companies. The largest payer was Janssen Biotech, Inc. with $30K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 39 | $30K |
| Lilly USA, LLC LLY | 28 | $27K |
| Abbvie Inc. ABBV | 48 | $19K |
| Pfizer Inc. PFE | 23 | $13K |
| Phathom Pharmaceuticals, Inc. PHAT | 14 | $4,125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 17 | $2,081 |
| Madrigal Pharmaceuticals MDGL | 20 | $439 |
| Gilead Sciences, Inc. GILD | 7 | $155 |
| Novo Nordisk Inc NVO | 3 | $149 |
| Eli Lilly and Company LLY | 1 | $142 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.